Clinical Trials in Weihai, China
Locations / Weihai, China
Delta Trials catalogs 69 clinical trials conducted in Weihai, China, making it a notable site of clinical research activity. These trials spanning 98 distinct medical conditions, reflecting the scope and diversity of clinical research in this location. All data is sourced directly from ClinicalTrials.gov and updated as trial registrations in Weihai evolve over time.
69
Total Trials
98
Conditions
0
Terminated since 2020
Browse by condition (98 total)
- Ischemic stroke, acute 5 trialsAll Ischemic stroke, acute trials
- Non-small cell lung cancer 4 trialsAll Non-small cell lung cancer trials
- Her2-positive breast cancer 3 trialsAll Her2-positive breast cancer trials
- COVID-19 3 trialsAll COVID-19 trials
- Acute ischemic stroke 2 trialsAll Acute ischemic stroke trials
- Ischemic stroke 2 trialsAll Ischemic stroke trials
- Breast cancer 2 trialsAll Breast cancer trials
- Intracerebral hemorrhage 2 trialsAll Intracerebral hemorrhage trials
- Transient ischemic attack 2 trialsAll Transient ischemic attack trials
- Severe adverse reactions 2 trialsAll Severe adverse reactions trials
- Adverse drug reactions 2 trialsAll Adverse drug reactions trials
- Breast neoplasms 2 trialsAll Breast neoplasms trials
- Stroke 2 trialsAll Stroke trials
- Drug-induced liver injury 1 trialAll Drug-induced liver injury trials
- All Her2-positive advanced breast with liver metastases trials
- Acute stroke 1 trialAll Acute stroke trials
- All Relapsed/refractory follicular lymphoma trials
- Severe adverse events 1 trialAll Severe adverse events trials
- All Her2 overexpressing gastric carcinoma trials
- All Intracranial atherosclerosis icas trials